Product Images Atripla
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Atripla NDC 15584-0101 by Gilead Sciences, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - atripla 01
Chemical Structure - atripla 02
Chemical Structure - atripla 03
PRINCIPAL DISPLAY PANEL - 30 Tablet Bottle Label - atripla 04
ATRIPLA is a tablet that includes 600 mg of efavirenz, 200 mg of emtricitabine, and 300 mg of tenofovir. It is manufactured by Gilead Sciences, LLC in Canada. The tablet is prescribed for patients who are infected with HIV-1. The package insert should be consulted for dosage and administration instructions. The ALERT box on the package should not be covered.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.